NR3C1 and depressive symptom measurement: This finding has been endorsed by Kim et al. (2016), who reported that the pathophysiological changes occur in depression including up-regulated proinflammatory cytokine secretion and functional resistance of glucocorticoid receptor in the hippocampus.